Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP17A1 | P05093 | 2/20 | 0.59 |
| ▸ | DRD2 | P14416 | 1/20 | 0.49 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.49 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.49 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.48 |
| ▸ | NAMPT | P43490 | 3/20 | 0.47 |
| ▸ | PSMB8 | P28062 | 1/20 | 0.47 |
| ▸ | PPARG | P37231 | 1/20 | 0.46 |
| ▸ | PPARA | Q07869 | 1/20 | 0.46 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.46 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.46 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.46 |
| ▸ | GLS | O94925 | 1/20 | 0.46 |
| ▸ | AURKA | O14965 | 1/20 | 0.44 |
| ▸ | RPS6KB1 | P23443 | 1/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | AKT1 | P31749 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16246084 | 0.89 | CYP17A1 (0.58) | CYP17A1DRD2PTGDR2MAPK14PTPN11 | |
| SCHEMBL132701 | 0.86 | CYP17A1 (0.76) | CYP17A1DRD2PTGDR2MAPK14PTPN11 | |
| SCHEMBL13055402 | 0.86 | CYP17A1 (0.59) | CYP17A1DRD2PTGDR2MAPK14PTPN11 | |
| SCHEMBL10361607 | 0.85 | CYP17A1 (0.61) | CYP17A1DRD2PTGDR2MAPK14NAMPT | |
| SCHEMBL6195004 | 0.85 | CYP17A1 (0.61) | CYP17A1DRD2PTGDR2MAPK14PTPN11 | |
| SCHEMBL245094 | 0.85 | CYP17A1 (0.61) | CYP17A1DRD2PTGDR2MAPK14PTPN11 | |
| SCHEMBL13160502 | 0.83 | CYP17A1 (0.59) | CYP17A1DRD2PTGDR2MAPK14PTPN11 | |
| SCHEMBL408439 | 0.83 | CYP17A1 (0.59) | CYP17A1DRD2PTGDR2MAPK14PTPN11 | |
| SCHEMBL31337626 | 0.83 | CYP17A1 (0.63) | CYP17A1DRD2PTGDR2MAPK14PTPN11 | |
| SCHEMBL243856 | 0.83 | CYP17A1 (0.59) | CYP17A1DRD2PTGDR2MAPK14PTPN11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130096092-A1 | THIOETHER PRODRUG COMPOSITIONS AS ANTI-HIV AND ANTI-RETROVIRAL AGENTS | HEALTH AND HUMAN SERVICES (US) | 2013-04-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130096092-A1 | THIOETHER PRODRUG COMPOSITIONS AS ANTI-HIV AND ANTI-RETROVIRAL AGENTS | SLC30A7, SLC30A6, SLC39A7 | CYP17A1 1886/4885DRD2 4344/4885PTGDR2 3689/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.